Tag: preclinical CRO market overview

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Estimated Growth Rate for the Preclinical CRO Market Between 2024 and 2033?

The preclinical CRO market has seen substantial growth in past years. The market size, which was projected at $5.15 billion in 2023, is expected to increase to $5.66 billion in 2024, thanks to a compound annual growth rate (CAGR) of 9.9%. Several factors contributed to this growth during the historic period, including the need for speedier drug development, cost-cutting strategies, emphasis on core skills, meeting regulatory compliance requirements, and the globalization of clinical trials.

Expectations are high for robust expansion in the preclinical CRO market size in the coming years. It’s projected to reach $7.94 billion by 2028, growing at a compound annual growth rate (CAGR) of 8.8%. The growth anticipated during this forecast period is linked to the surge in personalized medicine, the focus on rare ailments and orphan drugs, an uptick in outsourcing in the biopharmaceutical sector, as well as intensified biomarker research and the requirement for real-world evidence generation. Key trends expected to emerge during the forecast period are the incorporation of artificial intelligence (AI), broader oncology research, progress in omics technologies, advancements in in vitro and in vivo models, as well as collaborations in translational research.

Claim Your Free Sample of the Global Preclinical CRO Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=10303&type=smp

What Are the Primary Contributors to the Growth of the preclinical cro Market?

The preclinical CRO market is poised for growth, driven by the rising demand for preclinical trials. Preclinical trials, which are studies conducted on medicine or treatment methods before they are tested on human volunteers, play a pivotal role in drug development. They often involve new medical equipment, prescribed drugs, and diagnostics. The principal goals are to determine a safe starting dose for human research and assess possible toxicity levels of the product. As the focus on the safety and efficacy of new drugs intensifies, the significance of preclinical trials is also escalating. For instance, the National Library of Medicine in the US reported that by December 2021, 399,501 preclinical studies were carried out and by the close of 2022, a total of 437,536 preclinical trials were completed. Consequently, this surge in demand for preclinical trials is a significant driver for the growth of the preclinical CRO market.

Which Key Segments Comprise the Preclinical CRO Market?

1) By Service: Bioanalysis And DMPK Studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology, Others Services

2) By Type: Patient Derived Organoid (PDO) Model, Patient Derived Xenograft Model

3) By Animal Model: Small Animal Model, Large Animal Model

4) By Model System: In Vivo, In Vitro

5) By End User: Biopharmaceutical Companies, Government And Academic Institutes, Medical Device Companies, Other End-users

What Are the Key Trends Reshaping the Preclinical CRO Market?

Technological innovations are emerging as a significant trend in the preclinical CRO market. To maintain their market dominance, prominent companies in the preclinical CRO market are harnessing these new technologies. For example, in February 2023, BenchSci, a Canadian company leading in AI solutions for preclinical R&D, introduced ASCEND, a comprehensive SaaS (software as a service) platform for preclinical drug discovery. Utilizing this method allows for a greater understanding of the fundamental disease mechanisms and accelerates the preclinical phase of drug development. ASCEND applies BenchSci’s machine learning technology to extract experimental data from both secure internal and public external sources. The platform uses curated ontology datasets to contrast experimental outcomes. Consequently, the software can generate an evidence-based map of the biological processes behind different diseases.

Order Now for Fast Delivery of Your Preclinical CRO Market Report!

https://www.thebusinessresearchcompany.com/report/preclinical-cro-global-market-report

What Are the Top Regions Fueling Growth in the Preclinical CRO Market?

North America was the largest region in the preclinical CRO market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global preclinical CRO market during the forecast period. The regions covered in the preclinical cro market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Preclinical CRO Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the preclinical cro market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Preclinical CRO Market Include

1. Preclinical CRO Market Executive Summary

2. Preclinical CRO Market Segments

3. Preclinical CRO Market Size And Template Market Growth Rate

4. Key Preclinical CRO Market Trends

5. Major Preclinical CRO Market Drivers

……

25. Key Mergers And Acquisitions In The Preclinical CRO Market

26. Top Preclinical CRO Companies

27. Preclinical CRO Market Opportunities And Strategies

28. Preclinical CRO Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Industrial Controls Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/industrial-controls-global-market-report

Warehouse Automation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/warehouse-automation-global-market-report

Industrial Process Variable Instruments Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/industrial-process-variable-instruments-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Preclinical CRO Global Market Report 2024, the preclinical CRO market is expected to show promising growth in the forecast period.`

1. The Rising Trajectory of the Preclinical CRO Market

• The preclinical CRO market has experienced robust growth, rising from $5.15 billion in 2023 to an anticipated $5.66 billion in 2024, reflecting a CAGR of 9.9%.
• Historic growth drivers include the demand for expedited drug development, cost containment strategies, and regulatory compliance requirements.
• Globalization of clinical trials and a focus on core competencies have also fueled market expansion.

2. Projected Growth and Contributing Factors

• Forecasts suggest continued strong growth, with the market expected to reach $7.94 billion by 2028, boasting a CAGR of 8.8%.
• Anticipated growth drivers in the forecast period include personalized medicine, rare disease treatments, and increased outsourcing in biopharmaceuticals.
• Emphasis on biomarker research and the need for real-world evidence generation are expected to further fuel market expansion.

3. Surging Demand For Preclinical Trials Drives Growth

• Preclinical trials serve as a pivotal stage in drug development, ensuring safety and efficacy before human trials commence.
• The increasing emphasis on drug safety and efficacy has led to a rise in demand for preclinical trials, underscoring the market’s growth.
• Key players in the preclinical CRO market include Eurofins Scientific SE, PRA Health Sciences Inc., and Wuxi AppTec Co. Ltd.

 

View More On The Preclinical CRO Market Report 2024 – https://www.thebusinessresearchcompany.com/report/preclinical-cro-global-market-report

 

4. Revolutionizing Preclinical Drug Discovery

• Technological advancements are reshaping preclinical drug discovery, with companies leveraging AI and machine learning for accelerated research.
• BenchSci’s ASCEND platform exemplifies the integration of AI into preclinical R&D, expediting drug development pipelines.
• Innovation remains a driving force behind market growth, with companies adopting cutting-edge technologies to maintain competitiveness.

5. Asahi Kasei Medical’s Strategic Acquisition

• Asahi Kasei Medical’s acquisition of Bionova Scientific LLC underscores the industry’s consolidation and expansion efforts.
• The acquisition enhances Asahi Kasei Medical’s bioprocess portfolio, positioning it to cater to a broader customer base.
• Bionova Scientific’s expertise in contract process development and GMP-compliant manufacturing strengthens Asahi Kasei Medical’s market position.

6. Market Segmentation and Regional Dynamics

• The preclinical CRO market is segmented by service, type, animal model, model system, and end-user.
• Service offerings include bioanalysis, DMPK studies, toxicology testing, and compound management, among others.
• North America leads the market, with Asia-Pacific projected to witness the fastest growth during the forecast period.

Conclusion

• The preclinical CRO market is poised for significant expansion, driven by technological innovation, rising demand for preclinical trials, and strategic acquisitions.
• As the industry continues to evolve, stakeholders must remain agile and adaptive to capitalize on emerging opportunities and navigate evolving market dynamics.
• Collaboration, innovation, and a focus on delivering value-driven solutions will be critical for sustained growth and success in the dynamic preclinical CRO landscape.

Top of Form

 

Request A Sample Of The Global Preclinical CRO Market Report 2024:

https://www.thebusinessresearchcompany.com/sample_request?id=10303&type=smp